1. Home
  2. AHG vs INSP Comparison

AHG vs INSP Comparison

Compare AHG & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AHG

Akso Health Group ADS

N/A

Current Price

$1.53

Market Cap

1.8B

ML Signal

N/A

Logo Inspire Medical Systems Inc.

INSP

Inspire Medical Systems Inc.

HOLD

Current Price

$44.03

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AHG
INSP
Founded
2013
2007
Country
China
United States
Employees
N/A
1333
Industry
Business Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.3B
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
AHG
INSP
Price
$1.53
$44.03
Analyst Decision
Buy
Analyst Count
0
16
Target Price
N/A
$94.00
AVG Volume (30 Days)
14.3K
1.2M
Earning Date
08-14-2025
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
179.43
EPS
N/A
N/A
Revenue
N/A
$82,050,000.00
Revenue This Year
N/A
$8.02
Revenue Next Year
N/A
$8.11
P/E Ratio
N/A
N/A
Revenue Growth
N/A
62.18
52 Week Low
$1.08
$39.61
52 Week High
$2.50
$147.66

Technical Indicators

Market Signals
Indicator
AHG
INSP
Relative Strength Index (RSI) 28.14 39.79
Support Level $1.28 $39.61
Resistance Level $1.73 $59.40
Average True Range (ATR) 0.18 2.62
MACD -0.07 0.11
Stochastic Oscillator 1.43 50.00

Price Performance

Historical Comparison
AHG
INSP

About AHG Akso Health Group ADS

Akso Health Group is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.

About INSP Inspire Medical Systems Inc.

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.

Share on Social Networks: